Clik here to view.
武田药品工业株式会社公布2017年上半年业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO:4502)： 武田增长引擎带动基础营收增长了6.7% 基础营收增长+6.7%，各地区业务均斩获了不俗的业绩（美国+16.7%、日本 +0.3%、欧洲与加拿大 +4.2%、 新兴市场...
View ArticleClik here to view.
武田在美国血液学会第59届年会上呈报的数据有望重塑血液肿瘤治疗的未来
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:...
View ArticleClik here to view.
アヴェオ・オンコロジーとEUSA Pharma、腎細胞がんでチボザニブとニボルマブを検討する第1/2相TiNivo試験の第1相部分の有望な結果を発表
米マサチューセッツ州ケンブリッジ & 英ヘメルヘムステッド （ビジネスワイヤ） — アヴェオ・オンコロジー（NASDAQ:AVEO）とEUSA Pharmaは本日、TiNivo試験の進行中の第1相部分から得た有望な結果を報告したと発表しました。TiNivo試験は、進行性腎細胞がん（RCC）の治療を目的として、ブリストル・マイヤーズ...
View ArticleClik here to view.
EOC Pharma Completed Series B Financing From Leading Global Investors
SHANGHAI EOC Pharma Group (EOC), a leading oncology-focused development and commercialization company in China, today announced that it has completed a $32 million Series B financing led by Taikang...
View ArticleClik here to view.
Sterigenics International LLC Changes Name to Sotera Health LLC
CLEVELAND Sterigenics International LLC (the “Company”) announced today that it has changed its parent company name to Sotera Health LLC. Its three operating companies – Nelson Labs™, Nordion® and...
View ArticleClik here to view.
Chugai’s ALK Inhibitor “Alecensa®” Approved for the Treatment of First Line...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Genentech Inc., a member of the Roche Group, obtained approval from the U.S. Food and Drug Administration (FDA), for...
View ArticleClik here to view.
Seattle Genetics and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”), today announced dosing of the first patient...
View ArticleClik here to view.
武田薬品が第59回米国血液学会年次総会で血液がん治療の未来を再形成し得るデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
武田的ADCETRIS® (brentuximab vedotin)获得CHMP肯定意见，用于治疗CD30阳性皮肤T细胞淋巴瘤
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，欧洲药品管理局(EMA)人用药品委员会(CHMP)已采纳一项肯定意见，延长ADCETRIS® (brentuximab...
View ArticleClik here to view.
AstraZeneca to Present Transformative Data at ESMO Asia 2017 Congress from...
SINGAPORE At the ESMO Asia 2017 Congress in Singapore, 17-19 November 2017, AstraZeneca and MedImmune, its global biologics research and development arm, will share ground-breaking results from two...
View ArticleClik here to view.
武田薬品、CD30陽性皮膚T細胞リンパ腫の治療薬としてのアドセトリス（ブレンツキシマブ・ベドチン）に対する肯定的見解をCHMPより取得
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE:...
View ArticleClik here to view.
Samsung Bioepis Receives Regulatory Approval for Europe’s First Trastuzumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT®, a biosimilar referencing Herceptin® (trastuzumab), for the treatment of...
View ArticleClik here to view.
癌症患者、幸存者、支持者和照料者参与阿联酋首次生命接力
阿联酋沙迦 (美国商业资讯) — 阿联酋七个酋长国中第三大的沙迦主场举办MENA地区有史以来首次“全球生命接力”(RFL)， RFL是一次为期24小时的步行马拉松，是世界上最大的癌症募捐活动。该活动与美国癌症学会联合举办，组织方是“癌症患者之友”组织(Friends of Cancer Patients, FoCP)，FoCP是一家支持癌症患者及其家属的非营利组织。...
View ArticleClik here to view.
Clik here to view.
Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review...
TOKYO Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151) (President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announces that the U.S. Food and Drug Administration (FDA) has accepted for review the...
View ArticleClik here to view.
Novocure Receives Reimbursement Approval for Optune® in Japan for the...
ST. HELIER, Jersey Novocure (NASDAQ:NVCR) announced today that the Japanese Ministry of Health, Labour and Welfare has approved the recommendation by Japan’s Central Social Insurance Medical Council...
View ArticleClik here to view.
ノボキュア社、初発膠芽腫の治療を目的としたオプチューン日本における保険収載の承認を取得
ジャージー島セントヘリア （ビジネスワイヤ）– ノボキュア社（NASDAQ: NVCR）は本日、日本の厚生労働大臣が、中央社会保険医療協議会（中医協）の建議に基づき、初発膠芽腫の治療を目的としたオプチューンの保険収載を承認したと発表しました。...
View ArticleClik here to view.
PMC Group International Announces Acquisition of Pharma Company in France
MOUNT LAUREL, N.J. PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced the acquisition of the pharma business of...
View ArticleClik here to view.